RecruitingPhase 2/3
NCT07554456A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizuma…
This trial is a registrational Phase II/III, randomized, controlled, open-label, multicenter study to evaluate the efficacy and safety of BL-B01D1 in combinatio…
China90 participantsStarted 2026-06-09Updated 2026-07-16 Treatment: BL-B01D1, Tislelizumab
RecruitingPhase 3
NCT04415853Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
This is a randomized, controlled, multi-center, open trial, unresectable locally advanced or metastatic esophageal squamous cell carcinoma patients that failed…
China416 participantsStarted 2021-01-21Updated 2025-05-18 Treatment: Lerotinib, Irinotecan/Tegafur